Part II: Living with DMG, Xavier’s Story with Philip Tan

This podcast is a continuation of our March 3 show, “Living with DMG: Scientist Father Philip Tan blazes a Trail for Xavier“, where Xavier’s father Philip gave us and extensive window into the life of his family and how it had changed since the diagnosis of a deadly brain tumor. …

Continue reading

Life Beyond DIPG: Inspiration and Avocation

In this edition of Childhood Cancer Talk Radio, members of the DIPG Advocacy Group Gerry Tye (Syndey, AUS), Katherine Bader (Rhineland, Missouri) and Marcelo Ortigao (Fort Collins, CO) share their personal experiences with DIPG, one of the more common types of childhood brain cancer, and the deadliest with very few…

Continue reading

Keith Desserich and The Cure Starts Now

Keith Desserich, co-founder of The Cure Starts Now worldwide charity for pediatric brain tumor research, joins us today at this hopeful new year’s beginning. When Keith and his wife Brooke found out that their beautiful daughter Elena had DIPG, a devastating pediatric brain tumor, there were no dedicated clinical trials,…

Continue reading

Fight for Owen, Find A Cure -from South Africa

Candice Hamman and Carl Jansen VanVuuren tell the story of their son Owen who was diagnosed in June 2020 with DIPG, diffuse intrinsic pontine glioma.  There are no treatment options besides the standard radiation and palliative care, and purchase of the experimental ONC201 from Germany.  Candice and Carl share from…

Continue reading

The Clinical Trial System is failing America’s Children

Amanda Haddock, DragonMaster Foundation on Medium 8-20-2019 That may seem like a bold headline, but it isn’t click bait. This is a real problem facing many Americans (adults and children) in their most dire moments of need. The best way I can illustrate this is by telling you a story. It’s…

Continue reading

Oncoceutics: Real-Time Solutions for Cancer Treatment

Joshua Allen, Senior Vice President of Research and Development at Oncoceutics joins us to explain a novel group of compounds called imipridones that he helped to create which target specific mutations in an wide array of cancer types. ONC201, the first that he personally discovered, is now being used in…

Continue reading

Trailblazing to a Cure: DIPG-Treatment Advisory Council (G-TAC)

G-TAC founder and Executive Director of MaxCure Foundation Jonathan Agin, and G-TAC Medical Advisory Board Member Dr. Sabine Mueller, top neuro-oncology researcher and clinical expert at UCSF, discuss a new concierge-type service for families of the newly-diagnosed with DIPG (diffuse intrinsic pontine glioma) to more expediently direct them to more…

Continue reading